Qing Wang1, Luke Pittman2, Andrew Healey3, James Chang1, T Ted Song4. 1. From the Department of Medicine, Madigan Army Medical Center, Tacoma, Washington. 2. Department of Allergy/Immunology, Walter Reed National Military Medical Center, Bethesda, Maryland. 3. Department of Radiology, Womack Army Medical Center, Fort Bragg, North Carolina; and. 4. Department of Allergy/Immunology, University of Washington, Seattle, Washington.
Abstract
Background: Epinephrine is the first-line therapy for patients with anaphylaxis, and intramuscular (IM) delivery is shown to be superior to subcutaneous (SC) delivery. There currently is no consensus on the ideal body position for epinephrine autoinjector (EAI) administration. Objective: We designed this study to investigate whether SC tissue depth (SCTD) is affected by body position (e.g., standing, sitting, supine), which can potentially impact delivery of EAI into the IM space. Methods: Volunteer adults (ages ≥ 18 years) from a military medical treatment facility in the United States were recruited to participate in this study. SCTD of the vastus lateralis was measured via ultrasound at standing, sitting, and supine body positions. Subjects' age, sex, and body mass index (BMI) were collected. Statistical analysis was performed to compare average SCTD between body positions, sex, and BMI. Results: An analysis of variance of 51 participants (33 men and 18 women) did not reveal statistically significant difference in SCTD among standing, sitting, and supine body positions. It did show a significantly greater SCTD in women than in men (2.72 ± 1.36 cm versus 1.10 ± 0.38 cm; p < 0.001). There was no significant association observed between BMI and SCTD in this study. Conclusion: Body position did not seem to significantly change the distance between skin and thigh muscle in adults. This would suggest that there might not be an ideal body position for EAI administration. Therefore, in case of anaphylaxis, prompt administration of epinephrine is recommended at any position.
Background: Epinephrine is the first-line therapy for patients with anaphylaxis, and intramuscular (IM) delivery is shown to be superior to subcutaneous (SC) delivery. There currently is no consensus on the ideal body position for epinephrine autoinjector (EAI) administration. Objective: We designed this study to investigate whether SC tissue depth (SCTD) is affected by body position (e.g., standing, sitting, supine), which can potentially impact delivery of EAI into the IM space. Methods: Volunteer adults (ages ≥ 18 years) from a military medical treatment facility in the United States were recruited to participate in this study. SCTD of the vastus lateralis was measured via ultrasound at standing, sitting, and supine body positions. Subjects' age, sex, and body mass index (BMI) were collected. Statistical analysis was performed to compare average SCTD between body positions, sex, and BMI. Results: An analysis of variance of 51 participants (33 men and 18 women) did not reveal statistically significant difference in SCTD among standing, sitting, and supine body positions. It did show a significantly greater SCTD in women than in men (2.72 ± 1.36 cm versus 1.10 ± 0.38 cm; p < 0.001). There was no significant association observed between BMI and SCTD in this study. Conclusion: Body position did not seem to significantly change the distance between skin and thigh muscle in adults. This would suggest that there might not be an ideal body position for EAI administration. Therefore, in case of anaphylaxis, prompt administration of epinephrine is recommended at any position.
Authors: Phillip Lieberman; Richard A Nicklas; Christopher Randolph; John Oppenheimer; David Bernstein; Jonathan Bernstein; Anne Ellis; David B K Golden; Paul Greenberger; Steven Kemp; David Khan; Dennis Ledford; Jay Lieberman; Dean Metcalfe; Anna Nowak-Wegrzyn; Scott Sicherer; Dana Wallace; Joann Blessing-Moore; David Lang; Jay M Portnoy; Diane Schuller; Sheldon Spector; Stephen A Tilles Journal: Ann Allergy Asthma Immunol Date: 2015-11 Impact factor: 6.347
Authors: Katherine M Flegal; Deanna Kruszon-Moran; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden Journal: JAMA Date: 2016-06-07 Impact factor: 56.272
Authors: A Muraro; G Roberts; M Worm; M B Bilò; K Brockow; M Fernández Rivas; A F Santos; Z Q Zolkipli; A Bellou; K Beyer; C Bindslev-Jensen; V Cardona; A T Clark; P Demoly; A E J Dubois; A DunnGalvin; P Eigenmann; S Halken; L Harada; G Lack; M Jutel; B Niggemann; F Ruëff; F Timmermans; B J Vlieg-Boerstra; T Werfel; S Dhami; S Panesar; C A Akdis; A Sheikh Journal: Allergy Date: 2014-06-09 Impact factor: 13.146
Authors: Johannes Ring; Kirsten Beyer; Tilo Biedermann; Andreas Bircher; Dorothea Duda; Jörg Fischer; Frank Friedrichs; Thomas Fuchs; Uwe Gieler; Thilo Jakob; Ludger Klimek; Lars Lange; Hans F Merk; Bodo Niggemann; Oliver Pfaar; Bernhard Przybilla; Franziska Ruëff; Ernst Rietschel; Sabine Schnadt; Roland Seifert; Helmut Sitter; Eva-Maria Varga; Margitta Worm; Knut Brockow Journal: Allergo J Int Date: 2014